Jennifer Cannon, Ph.D.

Jennifer is the Executive Vice President and Global Head of Lonza’s Mammalian Biologics. Previously, she has led the Abbvie’s CMO team including global Commercial Development, Account Management, Business Development and Marketing. She has developed and executed effective growth strategy for a broad range of Abbvie’s CMO services and technologies, including Mammalian Biologics, Fill Finish, ADC, Microbial Fermentation, and Oral Solid Dose. Jennifer has managed the CMO business using innovative market development strategy paired with agile and accountable commercial operating processes to maximize network utilization, offset manufacturing costs and increase profitability. Jennifer received her Ph.D. in pharmacology from Johns Hopkins University, School of Medicine, an MS in molecular biology from the Salk Institute, and a BS in biochemistry from the University of California, San Diego. She attained her post-doctoral training at Genentech in the Department of Oncology.